Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus

Ischemic heart disease (IHD) and type-2 diabetes mellitus (T2DM) remain major health problems worldwide and commonly coexist in individuals. Gut microbial metabolites, such as trimethylamine <i>N</i>-oxide (TMAO) and short-chain fatty acids (SCFAs), have been linked to cardiovascular and...

Full description

Bibliographic Details
Main Authors: María José Sánchez-Quintero, Josué Delgado, Dina Medina-Vera, Víctor M. Becerra-Muñoz, María Isabel Queipo-Ortuño, Mario Estévez, Isaac Plaza-Andrades, Jorge Rodríguez-Capitán, Pedro L. Sánchez, Maria G. Crespo-Leiro, Manuel F. Jiménez-Navarro, Francisco Javier Pavón-Morón
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/21/4650
_version_ 1797466874362986496
author María José Sánchez-Quintero
Josué Delgado
Dina Medina-Vera
Víctor M. Becerra-Muñoz
María Isabel Queipo-Ortuño
Mario Estévez
Isaac Plaza-Andrades
Jorge Rodríguez-Capitán
Pedro L. Sánchez
Maria G. Crespo-Leiro
Manuel F. Jiménez-Navarro
Francisco Javier Pavón-Morón
author_facet María José Sánchez-Quintero
Josué Delgado
Dina Medina-Vera
Víctor M. Becerra-Muñoz
María Isabel Queipo-Ortuño
Mario Estévez
Isaac Plaza-Andrades
Jorge Rodríguez-Capitán
Pedro L. Sánchez
Maria G. Crespo-Leiro
Manuel F. Jiménez-Navarro
Francisco Javier Pavón-Morón
author_sort María José Sánchez-Quintero
collection DOAJ
description Ischemic heart disease (IHD) and type-2 diabetes mellitus (T2DM) remain major health problems worldwide and commonly coexist in individuals. Gut microbial metabolites, such as trimethylamine <i>N</i>-oxide (TMAO) and short-chain fatty acids (SCFAs), have been linked to cardiovascular and metabolic diseases. Previous studies have reported dysbiosis in the gut microbiota of these patients and the prebiotic effects of some components of the Mediterranean diet. Essential oil emulsions of savory (<i>Satureja hortensis</i>), parsley (<i>Petroselinum crispum</i>) and rosemary (<i>Rosmarinus officinalis</i>) were assessed as nutraceuticals and prebiotics in IHD and T2DM. Humanized mice harboring gut microbiota derived from that of patients with IHD and T2DM were supplemented with L-carnitine and orally treated with essential oil emulsions for 40 days. We assessed the effects on gut microbiota composition and abundance, microbial metabolites and plasma markers of cardiovascular disease, inflammation and oxidative stress. Our results showed that essential oil emulsions in mice supplemented with L-carnitine have prebiotic effects on beneficial commensal bacteria, mainly <i>Lactobacillus</i> genus. There was a decrease in plasma TMAO and an increase in fecal SCFAs levels in mice treated with parsley and rosemary essential oils. Thrombomodulin levels were increased in mice treated with savory and parsley essential oils. While mice treated with parsley and rosemary essential oils showed a decrease in plasma cytokines (INFɣ, TNFα, IL-12p70 and IL-22); savory essential oil was associated with increased levels of chemokines (CXCL1, CCL2 and CCL11). Finally, there was a decrease in protein carbonyls and pentosidine according to the essential oil emulsion. These results suggest that changes in the gut microbiota induced by essential oils of parsley, savory and rosemary as prebiotics could differentially regulate cardiovascular and metabolic factors, which highlights the potential of these nutraceuticals for reducing IHD risk in patients affected by T2DM.
first_indexed 2024-03-09T18:45:50Z
format Article
id doaj.art-32f44a5ee9c8473799e7e2fd3de80645
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T18:45:50Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-32f44a5ee9c8473799e7e2fd3de806452023-11-24T06:15:01ZengMDPI AGNutrients2072-66432022-11-011421465010.3390/nu14214650Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes MellitusMaría José Sánchez-Quintero0Josué Delgado1Dina Medina-Vera2Víctor M. Becerra-Muñoz3María Isabel Queipo-Ortuño4Mario Estévez5Isaac Plaza-Andrades6Jorge Rodríguez-Capitán7Pedro L. Sánchez8Maria G. Crespo-Leiro9Manuel F. Jiménez-Navarro10Francisco Javier Pavón-Morón11Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto Universitario de Investigación de Carne y Productos Cárnicos (IPROCAR), Universidad de Extremadura (UEX), 10003 Cáceres, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, SpainCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA-Plataforma BIONAND), 29590 Málaga, SpainIschemic heart disease (IHD) and type-2 diabetes mellitus (T2DM) remain major health problems worldwide and commonly coexist in individuals. Gut microbial metabolites, such as trimethylamine <i>N</i>-oxide (TMAO) and short-chain fatty acids (SCFAs), have been linked to cardiovascular and metabolic diseases. Previous studies have reported dysbiosis in the gut microbiota of these patients and the prebiotic effects of some components of the Mediterranean diet. Essential oil emulsions of savory (<i>Satureja hortensis</i>), parsley (<i>Petroselinum crispum</i>) and rosemary (<i>Rosmarinus officinalis</i>) were assessed as nutraceuticals and prebiotics in IHD and T2DM. Humanized mice harboring gut microbiota derived from that of patients with IHD and T2DM were supplemented with L-carnitine and orally treated with essential oil emulsions for 40 days. We assessed the effects on gut microbiota composition and abundance, microbial metabolites and plasma markers of cardiovascular disease, inflammation and oxidative stress. Our results showed that essential oil emulsions in mice supplemented with L-carnitine have prebiotic effects on beneficial commensal bacteria, mainly <i>Lactobacillus</i> genus. There was a decrease in plasma TMAO and an increase in fecal SCFAs levels in mice treated with parsley and rosemary essential oils. Thrombomodulin levels were increased in mice treated with savory and parsley essential oils. While mice treated with parsley and rosemary essential oils showed a decrease in plasma cytokines (INFɣ, TNFα, IL-12p70 and IL-22); savory essential oil was associated with increased levels of chemokines (CXCL1, CCL2 and CCL11). Finally, there was a decrease in protein carbonyls and pentosidine according to the essential oil emulsion. These results suggest that changes in the gut microbiota induced by essential oils of parsley, savory and rosemary as prebiotics could differentially regulate cardiovascular and metabolic factors, which highlights the potential of these nutraceuticals for reducing IHD risk in patients affected by T2DM.https://www.mdpi.com/2072-6643/14/21/4650carbonylcytokinechemokinenutraceuticalparsleypentosidine
spellingShingle María José Sánchez-Quintero
Josué Delgado
Dina Medina-Vera
Víctor M. Becerra-Muñoz
María Isabel Queipo-Ortuño
Mario Estévez
Isaac Plaza-Andrades
Jorge Rodríguez-Capitán
Pedro L. Sánchez
Maria G. Crespo-Leiro
Manuel F. Jiménez-Navarro
Francisco Javier Pavón-Morón
Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
Nutrients
carbonyl
cytokine
chemokine
nutraceutical
parsley
pentosidine
title Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
title_full Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
title_fullStr Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
title_full_unstemmed Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
title_short Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus
title_sort beneficial effects of essential oils from the mediterranean diet on gut microbiota and their metabolites in ischemic heart disease and type 2 diabetes mellitus
topic carbonyl
cytokine
chemokine
nutraceutical
parsley
pentosidine
url https://www.mdpi.com/2072-6643/14/21/4650
work_keys_str_mv AT mariajosesanchezquintero beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT josuedelgado beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT dinamedinavera beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT victormbecerramunoz beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT mariaisabelqueipoortuno beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT marioestevez beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT isaacplazaandrades beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT jorgerodriguezcapitan beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT pedrolsanchez beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT mariagcrespoleiro beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT manuelfjimeneznavarro beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus
AT franciscojavierpavonmoron beneficialeffectsofessentialoilsfromthemediterraneandietongutmicrobiotaandtheirmetabolitesinischemicheartdiseaseandtype2diabetesmellitus